Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/08/24 → 1/08/26 |
Keywords
- clinical trial
- Schizophrenia
- mental illness
A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in adult participants diagnosed with Schizophrenia
- Chen, Leo (Primary Chief Investigator (PCI))
Project: Research